A comparative study of wave 1 and 2 mortality factors among COVID-19 patients in a level 3 medical college hospital in Saharanpur India
DOI:
https://doi.org/10.3126/ajms.v13i5.41558Keywords:
COVID-19, Hypertension, Level 3 hospital, Mortality, T2DM, Wave 1, Wave 2Abstract
Background: In COVID-19, second wave death rate climbed in several states of India including Uttar Pradesh with relatively high number of casualties as compared to first wave. The literature lacks scientific reason behind this.
Aims and Objectives: The present study aimed toward detection of mortality factors for COVID-19 patients from a Level 3 Medical College Hospital in both waves in Western UP District in India so as to find a better treatment strategies for COVID-19 patients for possible next 3rd COVID-19 wave.
Materials and Methods: This study is aimed to find any difference in Wave 1 and 2 mortality factors among COVID-19 patients in a Level 3 Medical College Hospital in western up district Saharanpur in India from April 1, 2020 to Sep 30, 2021.
Results: Although there were more number of deaths in Wave 2 (n=537) as compared to Wave 1 (n=172), deaths even after treatment of COVID-19 were more in wave 1 (72%) as compared to wave 2 (67.9%), but it was not statistically significant (P>0.05). In COVID -19, Wave 1 most of the patients were elderly (aged >60 years) (40.3%) whereas in Wave 2 45–60 years age group were more affected (40.5%). Presence of more than 2 comorbidities was also seen more in wave 1 (37.1%) as compared to Wave 2 (23.8%). In COVID-19, both Waves (1 and 2) the most common co-morbidity was Type2DM (52% and 36.4%, respectively), but DM was found to be more in COVID+ve patients of Wave 1 as compared to wave 2 COVID+ve patients whereas any CARDIAC abnormality co-morbidity was found more in Wave 2 patients as compared to Wave 1 (14.2% vs. 12.1%).
Conclusion: Possibly COVID-19 virus operated differently at Cardio-respiratory system leading to increased mortality in COVID-19 patients in Wave 2.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).